←
BioPharm Intl6,730 posts
BioPharm Intl avatar

BioPharm Intl

@BioPharmIntl

Talking biopharmaceuticals, biotechnology, bioprocessing and related pharma manufacturing.

◷ Joined March 2011▧ 900 Photos and videos
BioPharm Intl avatar
BioPharm Intl@BioPharmIntl·Nov 16

A C1q-binding assay you can’t trust puts your antibody’s CDC story in question. On Nov. 18, Han Yang of sponsor WuXi Biologics shows how they qualified a label-free BLI method. Design & qualification results, free: hubs.li/Q04Fd_Qr0

Post attachment
BioPharm Intl avatar
BioPharm Intl@BioPharmIntl·Oct 26

Would your bispecific program hold up in a tech transfer tomorrow? Mispaired species and aggregation cut yield and investor confidence. How to catch them early, with FUJIFILM Biotechnologies: hubs.li/Q04ytbKC0

Post attachment
BioPharm Intl avatar
BioPharm Intl@BioPharmIntl·Oct 22

Cell therapy developers are pivoting from ex vivo to in vivo CAR-T. A 2026 review projects in vivo could cut treatment-course costs by 50% or more. Still a projection. 🔗 What in vivo still has to prove (free sign-in): hubs.li/Q04BTkQR0 #BioPharm #CellTherapy

0:23